The ultimate multiplex PCR platform for high-throughput processing
The RIDA®Jump can deliver results for up to 96 extracted samples in 3 hours with just 10 minutes of hands-on time.
Features & Benefits
Processes up to 96 samples per run
Automation for MT-PCR allows detection of up to 30 gene targets simultaneously
Streamlined efficiency – up to 3 TandemPlex® panels prepared concurrently
Faster processing with an 8-channel pipettor head
Samples per annum – 36,000 – 72,000
Total processing time (96 samples):
Step 1 MT-PCR 1 hr 45 mins
Step 2 MT-PCR & analysis 1 hr 15 mins
Total hands-on time:
10 mins
Features & Benefits
Processes up to 96 samples per run
Automation for MT-PCR allows detection of up to 30 gene targets simultaneously
Streamlined efficiency – up to 3 TandemPlex® panels prepared concurrently
Faster processing with an 8-channel pipettor head
Samples per annum – 36,000 – 72,000
Cost effective starting from 15 samples
Total processing time (96 samples):
Step 1 MT-PCR 1 hr 45 mins
Step 2 MT-PCR & analysis 1 hr 15 mins
Total hands-on time:
10 mins
High-precision liquid handling
Powerful pressure monitoring and swift liquid level detection safeguards the accuracy and precision of liquid handling by each of the eight pipette channels. Utilising air displacement non-contact dispensing, there is no need for system liquids, providing greater convenience, and lowering maintenance requirements. Easily exchangeable inline filters prevent liquid being drawn into the pipetting head to add security and protection for the device.
Streamlined efficiency
Simultaneous processing and preparation of microplates and test components greatly enhances throughput. The streamlined automatic process is programmed to ensure assay reproducibility and the most efficient application of resources.
News & Media
Acknowledgement of Country
R-Biopharm Australia acknowledges the traditional custodians of the land on which our office stands and pays tribute to the indigenous generations of the Gadigal nation, respecting elders past, present and future.